PET in lymphoma: what are the oncologist's needs?
- 4 April 2003
- journal article
- review article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 30 (1) , S37-S41
- https://doi.org/10.1007/s00259-003-1158-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Analysis of in-field control and late toxicity for adults with early-stage hodgkin’s disease treated with chemotherapy followed by radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2003
- The price of anticancer intervention. Secondary malignancies after radiotherapy.2002
- FDG PET in the management of lymphoma: a clinical perspectiveEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- British National Lymphoma Investigation: Pilot Studies of Neoadjuvant Chemotherapy in Clinical Stage Ia and IIa Hodgkin's DiseaseClinical Oncology, 2001
- Strategies to Reduce Deaths from Breast Cancer Following Mantle IrradiationClinical Oncology, 2000
- Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?European Journal Of Cancer, 2000
- 18-FDG-PET as a Prognostic Indicator in the Treatment of Aggressive Non-Hodgkin's Lymphoma-Comparison with CTLeukemia & Lymphoma, 2000
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998
- Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's LymphomaNew England Journal of Medicine, 1998
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993